Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Summa

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Angewandte Chemie (International Ed. in English)|July 13, 2016
Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple SclerosisMarco Migliore, Silvia Pontis, Angel Luis Fuentes de Arriba, et al.
Journal of Medicinal Chemistry|September 18, 2020
Identification, Structure-Activity Relationship, and Biological Characterization of 2,3,4,5-Tetrahydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indoles as a Novel Class of CFTR PotentiatorsNicoletta Brindani, Ambra Gianotti, Simone Giovani, et al.
Iscience|September 15, 2025
CDC42-effector interaction inhibitors alter patterns of vessel arborization in skin and tumors <i>in vivo</i>Linh M Vuong, Stephanie Hachey, Jessica Shiu, et al.
Journal of Medicinal Chemistry|September 1, 2021
Discovery and SAR Evolution of Pyrazole Azabicyclo[3.2.1]octane Sulfonamides as a Novel Class of Non-Covalent <i>N</i>-Acylethanolamine-Hydrolyzing Acid Amidase (NAAA) Inhibitors for Oral AdministrationPaolo Di Fruscia, Anna Carbone, Giovanni Bottegoni, et al.
Cell Reports|April 6, 2022
Structure-based design of CDC42 effector interaction inhibitors for the treatment of cancerSohail Jahid, Jose A Ortega, Linh M Vuong, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Angewandte Chemie (International Ed. in English)|July 13, 2016
Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple SclerosisMarco Migliore, Silvia Pontis, Angel Luis Fuentes de Arriba, et al.
Journal of Medicinal Chemistry|September 18, 2020
Identification, Structure-Activity Relationship, and Biological Characterization of 2,3,4,5-Tetrahydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indoles as a Novel Class of CFTR PotentiatorsNicoletta Brindani, Ambra Gianotti, Simone Giovani, et al.
Iscience|September 15, 2025
CDC42-effector interaction inhibitors alter patterns of vessel arborization in skin and tumors <i>in vivo</i>Linh M Vuong, Stephanie Hachey, Jessica Shiu, et al.
Journal of Medicinal Chemistry|September 1, 2021
Discovery and SAR Evolution of Pyrazole Azabicyclo[3.2.1]octane Sulfonamides as a Novel Class of Non-Covalent <i>N</i>-Acylethanolamine-Hydrolyzing Acid Amidase (NAAA) Inhibitors for Oral AdministrationPaolo Di Fruscia, Anna Carbone, Giovanni Bottegoni, et al.
Cell Reports|April 6, 2022
Structure-based design of CDC42 effector interaction inhibitors for the treatment of cancerSohail Jahid, Jose A Ortega, Linh M Vuong, et al.
Pageof 7